These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16913287)

  • 1. How do pharmaceutical companies approach data from sexual health studies for regulatory agencies?
    Dilleen M; Haughie S
    Annu Rev Sex Res; 2005; 16():53-61. PubMed ID: 16913287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive clinical trials for new drug applications in Japan.
    Ando Y; Hirakawa A; Uyama Y
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):175-9. PubMed ID: 20961739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated drug development through combined phase 2/3 clinical trial design.
    Cunningham ET; da Silva L; Harrison EM; Modi MW; O'Shaughnessy D; Guyer DR
    Arch Ophthalmol; 2004 Jul; 122(7):1043-4. PubMed ID: 15249371
    [No Abstract]   [Full Text] [Related]  

  • 4. The female sexual dysfunction (FSD) revolution reverts to evolution.
    Wyllie MG
    BJU Int; 2007 Sep; 100(3):697-8. PubMed ID: 17669148
    [No Abstract]   [Full Text] [Related]  

  • 5. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I.
    Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G
    Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved method of evaluating drug effect in a multiple dose clinical trial.
    Shen L
    Stat Med; 2001 Jul; 20(13):1913-29. PubMed ID: 11427949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing drugs for the treatment of female sexual dysfunction.
    Brown AD; Blagg J; Reynolds DS
    Drug Discov Today; 2007 Sep; 12(17-18):757-66. PubMed ID: 17826689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 25-year review of sequential methodology in clinical studies.
    Todd S
    Stat Med; 2007 Jan; 26(2):237-52. PubMed ID: 17139691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac repolarization and the safety of new drugs defined by electrocardiography.
    Morganroth J
    Clin Pharmacol Ther; 2007 Jan; 81(1):108-13. PubMed ID: 17186008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of predictive probabilities in phase II and phase III clinical trials.
    Johns D; Andersen JS
    J Biopharm Stat; 1999 Mar; 9(1):67-79. PubMed ID: 10091910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory perspective on clinical trials and end points for female sexual dysfunction, in particular, hypoactive sexual desire disorder: formulating recommendations in an environment of evolving clinical science.
    Shames D; Monroe SE; Davis D; Soule L
    Int J Impot Res; 2007; 19(1):30-6. PubMed ID: 16728969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female sexual dysfunction.
    Fitzhenry D; Sandberg L
    Nat Rev Drug Discov; 2005 Feb; 4(2):99-100. PubMed ID: 15756756
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation.
    Rowland D; Cooper S; Macias L
    Int J Impot Res; 2008; 20(2):115-20. PubMed ID: 17673935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The testosterone patch for women.
    Kingsberg SA
    Int J Impot Res; 2005; 17(5):465-6. PubMed ID: 16049522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.
    Röhmel J; Wassmer G
    Stat Med; 2004 Nov; 23(21):3393-4; author reply 3395-6. PubMed ID: 15493032
    [No Abstract]   [Full Text] [Related]  

  • 17. Anything new for the ladies in 2007?
    Wyllie MG
    BJU Int; 2007 Jan; 99(1):207-8. PubMed ID: 17227501
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical solutions have improved the treatment of sexological problems and created more demand for sexological care.
    Giraldi A; Kristensen E
    J Sex Marital Ther; 2007; 33(5):433-7. PubMed ID: 17674223
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality assurance in phase II and III studies.
    Wood DJ
    Qual Assur; 1993 Dec; 2(4):353-8. PubMed ID: 7952970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of phase II ALS clinical trials.
    Schoenfeld DA; Cudkowicz M
    Amyotroph Lateral Scler; 2008; 9(1):16-23. PubMed ID: 18273715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.